The Nordic subsidiary Glenmark Pharmaceuticals Nordic AB is based in Malmö, in Southern Sweden. Our high-quality generic pharmaceuticals are sold in all five Nordic markets, i.e. Sweden, Denmark, Norway, Finland and Iceland.
Since its inception in 2017, the Nordic business has grown rapidly and our portfolio includes many indication groups, focusing on the therapy areas of central nervous system, cardiovascular system and respiratory system.
Today, the Nordic team consists of 7 dedicated members from various Nordic geographies.